过去一年中添加的文章，按日期排序
Chemotherapy-induced high expression of IL23A enhances efficacy of anti-PD-1 therapy in TNBC by co-activating the PI3K-AKT signaling pathway of CTLs
F Pan, J Liu, Y Chen, B Zhu, W Chen, Y Yang, C Zhu… - Scientific Reports, 2024 - nature.com
17 天前 - … Treatment of advanced triple-negative breast cancer (TNBC… efficacy of immune
therapy on TNBC patients 10,11,12 . … Notably, combined treatment with pembrolizumab and …
therapy on TNBC patients 10,11,12 . … Notably, combined treatment with pembrolizumab and …
… mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy …
Q Chen, F Gao, J Wu, K Zhang, T Du… - … Medicine, 2024 - Wiley Online Library
17 天前 - … immunotherapy cohorts of skin cutaneous melanoma and triple-negative breast
cancer … patients with SKCM and 38 patients with triple-negative breast cancer (TNBC) before …
cancer … patients with SKCM and 38 patients with triple-negative breast cancer (TNBC) before …
[PDF][PDF] Predicting the Prognosis and Immunotherapeutic Response of Triple-Negative Breast Cancer by Constructing a Prognostic Model Based on CD8+ T Cell …
N Li, X Qiu, J Xue, L Yi, M Chen, Z Huang - Biomed Environ Sci, 2024 - besjournal.com
17 天前 - … (A, B) Triple-negative breast cancer singlecell sequencing UMAP cluster analysis
visualization, there are six different cell types from 13 clusters. (C) Number of different types of …
visualization, there are six different cell types from 13 clusters. (C) Number of different types of …
Multi‐omic analysis of dysregulated pathways in triple negative breast cancer
F Sajjad, A Jalal, A Jalal, Z Gul, H Mubeen… - Asia‐Pacific Journal of … - Wiley Online Library
17 天前 - … that can predict treatment response and guide personalized treatment decisions for
… subtype of breast cancer to treat, recent advances in targeted and immunotherapies, as well …
… subtype of breast cancer to treat, recent advances in targeted and immunotherapies, as well …
Turning Waste into Wealth: A Potent Sono‐Immune Strategy Based on Microcystis
Y Yang, J Ge, X Zhong, L Liu, L Chen, S Lu… - Advanced …, 2024 - Wiley Online Library
19 天前 - … immunotherapy based on Microcystis that achieved encouraging therapeutic effects
on cancer, … The “cold” 4T1 triple-negative breast cancer model was also used to validate the …
on cancer, … The “cold” 4T1 triple-negative breast cancer model was also used to validate the …
Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework
C Copeland, N Kotsopoulos, A Favre-Bulle… - Journal of Medical …, 2024 - Taylor & Francis
19 天前 - … two treatments: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant
… Triple negative breast cancer (TNBC) is a subtype of breast cancer lacking expression of …
… Triple negative breast cancer (TNBC) is a subtype of breast cancer lacking expression of …
Correspondence: Triple Negative Breast Cancer-A Brief Insight Into Pathophysiology
M Agrawal, AK Chowhan - Cancer Control, 2024 - journals.sagepub.com
19 天前 - … the tumor microenvironment can reveal new therapeutic targets such as immunotherapy
and targeted cell therapy… and resistance to therapy. Studies say, detection of circulating …
and targeted cell therapy… and resistance to therapy. Studies say, detection of circulating …
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
C Wang, L Yuan, X Wu, Y Wang, H Tian, G Zhang… - BMC medicine, 2024 - Springer
20 天前 - … breast cancer are considered triple-negative breast cancer (TNBC), a subtype of
breast cancer … the KEYNOTE-522 study, immunotherapy was not included in this trial, although …
breast cancer … the KEYNOTE-522 study, immunotherapy was not included in this trial, although …
Ferroptosis as a promising targeted therapy for triple negative breast cancer
K Mokhtarpour, S Razi, N Rezaei - … Cancer Research and Treatment, 2024 - Springer
23 天前 - … Triple negative breast cancer (TNBC) is a challenging subtype characterized … -cancer
therapies, including radiotherapy, immunotherapy, chemotherapy, and targeted therapy [3]…
therapies, including radiotherapy, immunotherapy, chemotherapy, and targeted therapy [3]…
Identification of disulfidptosis-related clusters and construction of a disulfidptosis-related gene prognostic signature in triple-negative breast cancer
J Wu, Y Cai, G Zhao - Heliyon, 2024 - cell.com
23 天前 - … This study aimed to explore disulfidptosis-related clusters of triple-negative breast
cancer (… to chemotherapy drugs such as lapatinib and had a lower immunotherapy response. …
cancer (… to chemotherapy drugs such as lapatinib and had a lower immunotherapy response. …